259 related articles for article (PubMed ID: 18391063)
1. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
Xu RH; Cohen M; Tang Y; Lazear E; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Exp Med; 2008 Apr; 205(4):981-92. PubMed ID: 18391063
[TBL] [Abstract][Full Text] [Related]
2. The Pathogenesis and Immunobiology of Mousepox.
Sigal LJ
Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G
PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266
[TBL] [Abstract][Full Text] [Related]
4. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
[TBL] [Abstract][Full Text] [Related]
5. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
6. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
7. The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.
Melo-Silva CR; Tscharke DC; Lobigs M; Koskinen A; Wong YC; Buller RM; Müllbacher A; Regner M
J Virol; 2011 Nov; 85(21):11170-82. PubMed ID: 21849445
[TBL] [Abstract][Full Text] [Related]
8. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Gratz MS; Suezer Y; Kremer M; Volz A; Majzoub M; Hanschmann KM; Kalinke U; Schwantes A; Sutter G
J Virol; 2011 Apr; 85(7):3557-69. PubMed ID: 21270149
[TBL] [Abstract][Full Text] [Related]
9. Ectromelia virus: the causative agent of mousepox.
Esteban DJ; Buller RML
J Gen Virol; 2005 Oct; 86(Pt 10):2645-2659. PubMed ID: 16186218
[TBL] [Abstract][Full Text] [Related]
10. Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.
Frey TR; Forsyth KS; Sheehan MM; De Haven BC; Pevarnik JG; Hand ES; Pizzorno MC; Eisenlohr LC; Hersperger AR
Virology; 2018 May; 518():335-348. PubMed ID: 29602068
[TBL] [Abstract][Full Text] [Related]
11. Comparative Pathogenesis, Genomics and Phylogeography of Mousepox.
Mavian C; López-Bueno A; Martín R; Nitsche A; Alcamí A
Viruses; 2021 Jun; 13(6):. PubMed ID: 34203773
[TBL] [Abstract][Full Text] [Related]
12. Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.
Lynn H; Horsington J; Ter LK; Han S; Chew YL; Diefenbach RJ; Way M; Chaudhri G; Karupiah G; Newsome TP
J Virol; 2012 Jul; 86(13):7427-43. PubMed ID: 22532690
[TBL] [Abstract][Full Text] [Related]
13. Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox.
Melo-Silva CR; Tscharke DC; Lobigs M; Koskinen A; Müllbacher A; Regner M
Virus Res; 2017 Jan; 228():61-65. PubMed ID: 27865865
[TBL] [Abstract][Full Text] [Related]
14. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
[TBL] [Abstract][Full Text] [Related]
15. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.
Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A
PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
17. Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.
Xu RH; Rubio D; Roscoe F; Krouse TE; Truckenmiller ME; Norbury CC; Hudson PN; Damon IK; Alcamí A; Sigal LJ
PLoS Pathog; 2012 Jan; 8(1):e1002475. PubMed ID: 22241999
[TBL] [Abstract][Full Text] [Related]
18. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox.
Chen N; Buller RM; Wall EM; Upton C
Virus Res; 2000 Feb; 66(2):155-73. PubMed ID: 10725549
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
[TBL] [Abstract][Full Text] [Related]
20. The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.
Ma X; Xu RH; Roscoe F; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Virol; 2013 Jun; 87(12):7046-53. PubMed ID: 23596297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
